CWG
SIOX

C WorldWide Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

C WorldWide Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,113
Closed -$384K – 128
2017
Q4 		$384K Sell
9,113
-887
-9% -$39.8K 0.01% 112
2017
Q3 		$550K Sell
10,000
-6,438
-39% -$1.09M 0.01% 113
2017
Q2 		$3.05M Buy
16,438
+2,738
+20% +$480K 0.05% 80
2017
Q1 		$1.64M Buy
+13,700
New +$1.44M 0.03% 92

Other funds holding SIOX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

C WorldWide Group's SIOX Position: Q1 2018 in Review

C WorldWide Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2018, closing a stake of 9,113 shares — an estimated $384K sold.

C WorldWide Group first reported a position in SIOX in Q1 2017 and held it in 4 quarters. The position peaked at $3.05M in Q2 2017. 81 funds tracked by Wall St. Rank hold SIOX as of Q1 2018.

  • C WorldWide Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • C WorldWide Group sold 9,113 Sio Gene Therapies Inc. Common Stock shares in Q1 2018, an estimated $384K.
  • C WorldWide Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • C WorldWide Group's Sio Gene Therapies Inc. Common Stock position peaked at $3.05M in Q2 2017.
  • 81 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2018.

Based on C WorldWide Group's 13F filing for Q1 2018, filed 3 May 2018.